Compare ASPN & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASPN | ETON |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 573.2M | 498.8M |
| IPO Year | 2014 | 2018 |
| Metric | ASPN | ETON |
|---|---|---|
| Price | $2.92 | $16.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $13.00 | ★ $29.67 |
| AVG Volume (30 Days) | ★ 2.0M | 211.3K |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $352,852,000.00 | $70,316,000.00 |
| Revenue This Year | N/A | $107.23 |
| Revenue Next Year | N/A | $29.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 102.77 |
| 52 Week Low | $2.80 | $11.09 |
| 52 Week High | $14.30 | $23.00 |
| Indicator | ASPN | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 45.11 |
| Support Level | $2.80 | $16.53 |
| Resistance Level | $3.05 | $17.33 |
| Average True Range (ATR) | 0.16 | 0.64 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 17.89 | 32.91 |
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.